Mylan ($MYL) may have just caught a big break. Sanofi ($SNY) pulled the main competitor for EpiPen--Auvi-Q--from the market, a turn of events that should keep Mylan ...
Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice guidance, AUVI-Q ® (epinephrine injection), ...
AUVI-Q (epinephrine) 0.15mg and 0.3mg auto-injector pack Sanofi announced that the FDA has approved Auvi-Q (epinephrine injection) for the emergency treatment of life-threatening allergic reactions in ...
Sanofi has received the US Food and Drug Administration (FDA) approval for Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results